KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Change in Acquisitions & Divestments (2016 - 2023)

Amgen (AMGN) has 15 years of Change in Acquisitions & Divestments data on record, last reported at -$575.0 million in Q4 2023.

  • For Q4 2023, Change in Acquisitions & Divestments fell 64.76% year-over-year to -$575.0 million; the TTM value through Sep 2024 reached -$575.0 million, down 174.1%, while the annual FY2023 figure was $550.0 million, 461.22% up from the prior year.
  • Change in Acquisitions & Divestments reached -$575.0 million in Q4 2023 per AMGN's latest filing, down from $1.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $10.5 billion in Q1 2019 and bottomed at -$10.2 billion in Q2 2019.
  • Average Change in Acquisitions & Divestments over 5 years is $970.0 million, with a median of $1.1 billion recorded in 2023.
  • The widest YoY moves for Change in Acquisitions & Divestments: up 1860.61% in 2019, down 11108.6% in 2019.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $5.8 billion in 2019, then tumbled by 95.55% to $259.0 million in 2020, then tumbled by 1460.62% to -$3.5 billion in 2021, then soared by 90.1% to -$349.0 million in 2022, then tumbled by 64.76% to -$575.0 million in 2023.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were -$575.0 million in Q4 2023, $1.0 million in Q2 2023, and $1.1 billion in Q1 2023.